LivaNova (LIVN) Receivables (2015 - 2026)
LivaNova's (LIVN) quarterly Receivables came in at $229.3 million in Q1 2026, up 8.82% year-on-year from $210.7 million in Q1 2025, and up 5.86% quarter-over-quarter from $216.6 million in Q4 2025.
LivaNova (LIVN) Receivables (2015 - 2026) Analysis & Trends
LivaNova has disclosed Receivables across 12 years of filings, most recently posting $229.3 million for Q1 2026.
- Receivables for Q1 2026 came in at $229.3 million, up 8.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $229.3 million (up 8.82% YoY), and the FY2025 annual result was $216.6 million, up 10.24% from the prior year.
- Receivables came in at $229.3 million for Q1 2026 at LivaNova, up from $216.6 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $229.8 million in Q2 2025 to a low of $172.1 million in Q3 2022.
- The 5-year median for Receivables is $197.2 million (2024), against an average of $199.1 million.
- Across the five-year window, Receivables increased 17.46% in 2023 and fell 8.65% in 2024, its largest moves.
- LivaNova's Receivables stood at $183.1 million in 2022, then advanced by 17.46% to $215.1 million in 2023, then decreased by 8.65% to $196.5 million in 2024, then advanced by 10.24% to $216.6 million in 2025, then grew by 5.86% to $229.3 million in 2026.
- The last three Receivables figures came in at $229.3 million (Q1 2026), $216.6 million (Q4 2025), and $211.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 8.21 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.57 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 6.36 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 3.15 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 973.00 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.82 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1.11 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 4.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.09 Bn |
| 10 | LivaNova | 4.29 Bn | 3.71 Bn | 243.75 Mn | 229.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 229.27 Mn |
| Dec 31, 2025 | 216.59 Mn |
| Sep 30, 2025 | 211.58 Mn |
| Jun 30, 2025 | 229.80 Mn |
| Mar 31, 2025 | 210.68 Mn |
| Dec 31, 2024 | 196.46 Mn |
| Sep 30, 2024 | 197.16 Mn |
| Jun 30, 2024 | 200.89 Mn |
| Mar 31, 2024 | 209.43 Mn |
| Dec 31, 2023 | 215.07 Mn |
| Sep 30, 2023 | 189.87 Mn |
| Jun 30, 2023 | 185.88 Mn |
| Mar 31, 2023 | 178.32 Mn |
| Dec 31, 2022 | 183.11 Mn |
| Sep 30, 2022 | 172.09 Mn |
| Jun 30, 2022 | 176.95 Mn |
| Mar 31, 2022 | 182.11 Mn |
| Dec 31, 2021 | 185.35 Mn |
| Sep 30, 2021 | 182.01 Mn |
| Jun 30, 2021 | 182.18 Mn |